Cargando…

Eradication of HCV in Renal Transplant Recipients and Its Effects on Quality of Life

BACKGROUND: The use of direct antiviral agents (DAA) has radically modified the course of HCV hepatitis in renal patients. Aim of this study was to assess the effects of HCV eradication on quality of life (QOL) in renal transplant recipients (RTR), measured by CLDQ and SF-36. METHODS: Sixteen RTR wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sabbatini, Massimo, Capuano, Ivana, Camera, Silvia, Ferreri, Lucia, Buonanno, Pasquale, Donnarumma, Laura, Caporaso, Nicola, Morisco, Filomena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136566/ https://www.ncbi.nlm.nih.gov/pubmed/30246027 http://dx.doi.org/10.1155/2018/8953581

Ejemplares similares

Eradication of HCV Infection with the Direct-Acting Antiviral Therapy in Renal Allograft Recipients
por: Armando, Calogero, et al.
Publicado: (2019)

Erratum to “Eradication of HCV Infection with the Direct-Acting Antiviral Therapy in Renal Allograft Recipients”
por: Calogero, Armando, et al.
Publicado: (2019)

Timing Strategies of Direct-Acting Antivirals and Biologics Administration in HCV-Infected Subjects with Inflammatory Bowel Diseases
por: Imperatore, Nicola, et al.
Publicado: (2017)

Dilemma of HCV Infection in Renal Transplant Recipients
por: Ashry Ahmed Gheith, Osama
Publicado: (2011)

Lack of evidence of viral reactivation in HBsAg-negative HBcAb-positive and HCV patients undergoing immunosuppressive therapy for psoriasis
por: Morisco, Filomena, et al.
Publicado: (2014)

Stepwise shortening of agalsidase beta infusion duration in Fabry disease: Clinical experience with infusion rate escalation protocol
por: Riccio, Eleonora, et al.
Publicado: (2021)

Liver resection is always a good choice for hepatocellular carcinoma (HCC) patients regardless of Barcelona Clinic Liver Cancer (BCLC) stage: the therapeutic hierarchy
por: Guarino, Maria, et al.
Publicado: (2020)

Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: a pilot case–control study
por: Morisco, Filomena, et al.
Publicado: (2018)

Beneficial Effects of Silybin Treatment After Viral Eradication in Patients With HCV-Related Advanced Chronic Liver Disease: A Pilot Study
por: Cossiga, Valentina, et al.
Publicado: (2022)

The Psychosocial Burden of HCV Infection and the Impact of Antiviral Therapy on the Quality of Life in Liver and Kidney Transplant Recipients: A Pilot Study
por: Santonicola, Antonella, et al.
Publicado: (2020)

Transplantation of Renal Allografts From Organ Donors Reactive for HCV Antibodies to HCV-Negative Recipients: Safety and Clinical Outcome
por: Nowak, Knut Michael, et al.
Publicado: (2016)

HCV-infected Renal Transplant Recipients: Our Experience before the Availability of New Antiviral Drugs
por: Fernandes, A. R., et al.
Publicado: (2017)

The use of HCV positive donors among non-HCV infected liver transplant recipients
por: Zaffar, Duha, et al.
Publicado: (2022)

Pain in Fabry Disease: Could Spinal Cord Stimulation be a Solution?
por: Buonanno, Pasquale, et al.
Publicado: (2023)

Transplantation of HCV Viremic Livers into HCV Viremic Recipients Followed by Direct-acting Antiviral Therapy
por: Kapila, Nikhil, et al.
Publicado: (2019)

Conversion from Tacrolimus to Cyclosporine A Improves Glucose Tolerance in HCV-Positive Renal Transplant Recipients
por: Handisurya, Ammon, et al.
Publicado: (2016)

Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows
por: Guarino, Maria, et al.
Publicado: (2018)

Donor Small-Droplet Macrovesicular Steatosis Affects Liver Transplant Outcome in HCV-Negative Recipients
por: Ferri, Flaminia, et al.
Publicado: (2019)

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
por: Garbuglia, Anna Rosa, et al.
Publicado: (2014)

Randomized Controlled Trials on Renin Angiotensin Aldosterone System Inhibitors in Chronic Kidney Disease Stages 3–5: Are They Robust? A Fragility Index Analysis
por: Capuano, Ivana, et al.
Publicado: (2022)

Efficacy of a reduced pill burden on therapeutic adherence to calcineurin inhibitors in renal transplant recipients: an observational study
por: Sabbatini, Massimo, et al.
Publicado: (2014)

BK virus salivary shedding and viremia in renal transplant recipients
por: Sarmento, Dmitry José de Santana, et al.
Publicado: (2019)

Helicobacter pylori eradication in renal transplant candidates
por: Maioli, Mariana E., et al.
Publicado: (2022)

Telemedicine in the COVID-19 era for Liver Transplant Recipients: an Italian lockdown area experience
por: Santonicola, Antonella, et al.
Publicado: (2021)

Tuberculosis in renal transplant recipients
por: Sundaram, Madhivanan, et al.
Publicado: (2008)

Tuberculosis in renal transplant recipient
por: Kalita, P., et al.
Publicado: (2010)

Adipocytokines in renal transplant recipients
por: Nagy, Kristof, et al.
Publicado: (2016)

Infection in Renal Transplant Recipients
por: Kotton, Camille Nelson, et al.
Publicado: (2010)

Infection in Renal Transplant Recipients
por: Fishman, Jay A., et al.
Publicado: (2008)

Infection in Renal Transplant Recipients
por: Fishman, Jay A., et al.
Publicado: (2005)

Infection in Renal Transplant Recipients
por: Sawinski, Deirdre, et al.
Publicado: (2019)

Hemoptysis in Renal Transplant Recipients
por: Georgakopoulou, Vasiliki Epameinondas, et al.
Publicado: (2021)

Superior outcomes in HIV-positive kidney transplant patients compared to HCV-infected or HIV/HCV co-infected recipients
por: Sawinski, Deirdre, et al.
Publicado: (2015)

COVID-19 in liver transplant recipients: incidence, hospitalization and outcome in an Italian prospective double-centre study
por: Guarino, Maria, et al.
Publicado: (2022)

Telomere Length Increase in HIV/HCV-Coinfected Patients with Cirrhosis after HCV Eradication with Direct-Acting Antivirals (†)
por: Molina-Carrión, Silvia, et al.
Publicado: (2020)

Effect of Paricalcitol vs Calcitriol on Hemoglobin Levels in Chronic Kidney Disease Patients: A Randomized Trial
por: Riccio, Eleonora, et al.
Publicado: (2015)

Dietary Intake as a Link between Obesity, Systemic Inflammation, and the Assumption of Multiple Cardiovascular and Antidiabetic Drugs in Renal Transplant Recipients
por: Guida, Bruna, et al.
Publicado: (2013)

Treatment of HCV Patients Before and After Renal Transplantation
por: Du, Ling-yao, et al.
Publicado: (2011)

miRNA expression profiles in liver grafts of HCV and HIV/HCV‐infected recipients, 6 months after liver transplantation
por: Bulfoni, Michela, et al.
Publicado: (2021)

Lymphoma Remission by Interferon-Free HCV Eradication Without Chemotherapy
por: Lim, Lucy Y., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_kcpn0llm6q01al0sc25k69on6h